Swedish Auto Stock News

Bravida Holding (OM:BRAV) has been appointed technical partner for Dansk Data Center 1 at the Port of Esbjerg, where it will handle most core installations. The confidential contract is described as a medium-sized data centre project. See our latest analysis for Bravida Holding. The Dansk Data Center 1 contract comes at a time when Bravida Holding’s recent momentum has been firm, with a 90 day share price return of 17.66% and a 1 year total shareholder return of 46.92%. However, the 30 day...

Skanska (OM:SKA B) is back in focus after a series of large United States contract wins, highlighted by a joint venture agreement for the East San Fernando Valley Light Rail Transit Project in Los Angeles. See our latest analysis for Skanska. Set against this run of large United States contract wins and leadership changes, Skanska’s share price at SEK262.3 reflects a 1-month share price return of 1.98% and a 3-month share price return of 7.32%. Its 1-year total shareholder return of 15.42%...

The new licensing agreement between PayRange and Electrolux Professional to embed mobile payments in commercial laundry systems has pushed AB Electrolux (OM:ELUX B) back into focus as investors reassess margins, cash flow and valuation. See our latest analysis for AB Electrolux. At a share price of SEK28.34, AB Electrolux has seen a 1 month share price return of 22.79%, while the 1 year total shareholder return is down 13.42% and the 5 year total shareholder return is down 71.88%. This...

In August 2026, the European market has been navigating a complex landscape marked by resilient economic data and solid corporate earnings, yet tempered by geopolitical uncertainties and fluctuating energy prices. As investors seek promising opportunities in this environment, growth companies with high insider ownership stand out for their potential alignment of management interests with shareholder value, offering a compelling proposition amid ongoing market volatility.

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Investment AB Latour stock came into today on the back foot, with the share price down over the past week, month and quarter, and closing at SEK191.25 just as the new earnings landed. The immediate question for you is simple. Do the fresh numbers justify that cooling, or is the market leaning too hard on the short term? The headline this time is not revenue growth or order intake. It is pressure on profitability and valuation. Net profit margin over the last 12 months sits at 16.1% compared...

Bahnhof stock came into this earnings print carrying a rich 34.4x P/E and a reputation as a premium telecom play, yet the 1 day move around SEK59.6 suggests investors are still weighing what they really own. The headline is not the top line. Total revenue in Q2 landed at SEK575.9m, but the focus is on profit quality in a business that has seen net profit margin sit at 8.2% over the last year while dividends are not well covered by earnings or free cash flow. Love Bahnhof's premium P/E and...

The mRNA cancer vaccine breakthrough from Moderna and Merck has pushed this once speculative corner of biotech into the spotlight, and investors are taking notice of how quickly expectations can reset when trial data shifts the story. That kind of sharp repricing can create both opportunity and risk if you are exposed to similar news. This article walks through 3 stocks linked to this catalyst so you can judge whether they still fit your portfolio. The three stocks below are a useful sample...

As European markets navigate geopolitical uncertainties and fluctuating energy prices, the pan-European STOXX Europe 600 Index recently experienced a slight decline. However, resilient economic data and solid corporate earnings provide a foundation for identifying undervalued stocks that may offer potential value opportunities in this complex landscape.

As European markets navigate resilient economic data and geopolitical uncertainties, the pan-European STOXX Europe 600 Index recently experienced a slight decline, reflecting investor caution. Amidst these conditions, growth companies with high insider ownership often attract attention due to their potential alignment of interests and confidence in long-term prospects.

The European market has recently seen mixed performance, with the STOXX Europe 600 Index ending slightly down amid resilient economic data and geopolitical uncertainties. In this context, penny stocks—typically smaller or newer companies—continue to attract attention for their potential to offer hidden value. While the term "penny stocks" may seem outdated, these investments can still provide opportunities for those who focus on companies with strong financials and growth prospects.

As European markets navigate a landscape marked by resilient economic data and geopolitical uncertainties, the pan-European STOXX Europe 600 Index recently experienced a slight decline. Amid these conditions, investors are increasingly drawn to dividend stocks that offer potential income stability and resilience against market volatility.

Assassination plots against EU defence executives have pushed corporate security out of the shadows and into the core of risk management. When boardrooms start thinking about armoured transport, facility hardening and close protection, money often follows. For investors, that can mean fresh attention on a niche set of stocks exposed to the same threats they help address. This article unpacks three such European security providers and how this backdrop touches their investment case. The stocks...

As global markets navigate a complex landscape marked by easing inflation concerns, fluctuating oil prices, and mixed consumer data, small-cap indices like the Russell 2000 and S&P MidCap 400 have shown resilience with notable gains. Amid this backdrop, investors are increasingly seeking hidden opportunities within the small-cap segment that can offer potential growth despite broader market uncertainties. In such an environment, identifying promising stocks involves looking for companies...

The European market has recently faced mixed performance, with the pan-European STOXX Europe 600 Index ending slightly lower amid resilient economic data and geopolitical uncertainties. In this environment, small-cap stocks can offer unique opportunities for investors seeking growth potential, particularly when there is evidence of insider buying as a sign of confidence in a company's future prospects.

Those following along with Fabege AB (publ) ( STO:FABG ) will no doubt be intrigued by the recent purchase of shares by...

It's been a good week for BTS Group AB (publ) ( STO:BTS B ) shareholders, because the company has just released its...

Investors who take an interest in Mangold Fondkommission AB ( STO:MANG ) should definitely note that the Chairman of...

Björn Borg AB (publ) ( STO:BORG ) missed earnings with its latest second-quarter results, disappointing...

What Sinch’s new Agent Tools launch means for the stock Sinch (OM:SINCH) has rolled out Agent Tools, a global suite that lets developers build and test communications apps inside familiar coding environments and AI assistants, including GitHub Copilot, Claude Code and ChatGPT Desktop. See our latest analysis for Sinch. For context, Sinch’s share price is SEK43.97, with a 1 month share price return of 12.57% and a year to date share price return of 43.32%. The 1 year total shareholder return...

Kjell Group stock closed at SEK13.9 on Tuesday after a muted few weeks, with the 30 day move roughly flat despite a solid rebound in the latest quarter. The headline is simple: losses are still there, yet the profit squeeze is easing. Q2 basic earnings per share came in at a loss of SEK0.13 on revenue of SEK574.25m, an improvement from the deeper loss in Q1. For short term traders that may not move the needle much. For longer term investors the real story is whether this gradual repair in...

Swedish Orphan Biovitrum (OM:SOBI) has moved into rare oncology with a new agreement with Innate Pharma that supports the TELLOMAK-3 Phase 3 trial of lacutamab in cutaneous T cell lymphoma. See our latest analysis for Swedish Orphan Biovitrum. The Innate Pharma agreement comes as Swedish Orphan Biovitrum trades at SEK457.8, with a year to date share price return of 38.56% and a 1 year total shareholder return of 62.92%. This suggests momentum has been building over the past year. If this move...

In recent weeks, global markets have experienced a mixed performance, with indices like the Russell 2000 and S&P MidCap 400 showing gains amid easing inflation concerns and fluctuating oil prices. As investors navigate these dynamic conditions, identifying promising small-cap stocks that may not yet be on everyone's radar can offer unique opportunities for growth. In this context, finding a good stock often involves looking beyond the headlines to discover companies with strong fundamentals...

The European market has experienced a mix of resilient economic data and geopolitical uncertainties, with the pan-European STOXX Europe 600 Index recently ending the week down slightly. Despite these challenges, small-cap stocks in Europe remain an area of interest for investors seeking opportunities, especially when insider actions suggest potential undervaluation. In such a dynamic environment, identifying stocks with strong fundamentals and strategic insider activity can be crucial for...